PT2723774T - Método de fabrico de derivados de hidroxietilamido - Google Patents

Método de fabrico de derivados de hidroxietilamido

Info

Publication number
PT2723774T
PT2723774T PT12737229T PT12737229T PT2723774T PT 2723774 T PT2723774 T PT 2723774T PT 12737229 T PT12737229 T PT 12737229T PT 12737229 T PT12737229 T PT 12737229T PT 2723774 T PT2723774 T PT 2723774T
Authority
PT
Portugal
Prior art keywords
starch derivatives
hydroxyethyl starch
manufacturing
manufacturing hydroxyethyl
derivatives
Prior art date
Application number
PT12737229T
Other languages
English (en)
Inventor
Zimmermann Werner
Lukowczyk Jan
Original Assignee
Serumwerk Bernburg Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44799422&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT2723774(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Serumwerk Bernburg Ag filed Critical Serumwerk Bernburg Ag
Publication of PT2723774T publication Critical patent/PT2723774T/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/12Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof
    • A61K33/26Iron; Compounds thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/08Ethers
    • C08B31/10Alkyl or cycloalkyl ethers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00Preparation of derivatives of starch
    • C08B31/18Oxidised starch
    • C08B31/185Derivatives of oxidised starch, e.g. crosslinked oxidised starch

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT12737229T 2011-06-21 2012-06-21 Método de fabrico de derivados de hidroxietilamido PT2723774T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP11170761A EP2537866A1 (en) 2011-06-21 2011-06-21 Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof

Publications (1)

Publication Number Publication Date
PT2723774T true PT2723774T (pt) 2019-07-15

Family

ID=44799422

Family Applications (1)

Application Number Title Priority Date Filing Date
PT12737229T PT2723774T (pt) 2011-06-21 2012-06-21 Método de fabrico de derivados de hidroxietilamido

Country Status (21)

Country Link
US (2) US9181353B2 (pt)
EP (2) EP2537866A1 (pt)
JP (2) JP6370217B2 (pt)
CN (2) CN105348401A (pt)
BR (1) BR112013032901A2 (pt)
CA (1) CA2837784C (pt)
CY (1) CY1121976T1 (pt)
DK (1) DK2723774T3 (pt)
ES (1) ES2733767T3 (pt)
HK (1) HK1220218A1 (pt)
HR (1) HRP20191173T1 (pt)
HU (1) HUE044428T2 (pt)
LT (1) LT2723774T (pt)
MX (1) MX337682B (pt)
PL (1) PL2723774T3 (pt)
PT (1) PT2723774T (pt)
RS (1) RS59021B1 (pt)
SI (1) SI2723774T1 (pt)
TR (1) TR201909574T4 (pt)
TW (1) TWI564010B (pt)
WO (1) WO2012175608A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6616725B2 (ja) * 2016-03-31 2019-12-04 日本製紙株式会社 塗工紙用澱粉
SG11202107050RA (en) 2019-01-10 2021-07-29 Pharmacosmos Holding As Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation
EA202191858A1 (ru) 2019-06-12 2021-11-12 Фармакосмос Холдинг А/С Лечение дефицита железа у субъектов с риском нежелательных явлений со стороны сердечно-сосудистой системы и железо для лечения фибрилляции предсердий
CN118019542A (zh) 2021-08-03 2024-05-10 法码科思莫斯控股有限公司 用于在治疗伴侣动物缺铁中皮下使用的铁络合化合物
CN117547549A (zh) * 2023-11-09 2024-02-13 黑龙江八一农垦大学 适用于犬arf的腹膜透析液与助清除剂的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3639588A (en) * 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
US4370476A (en) * 1979-07-17 1983-01-25 Usher Thomas C Dextran polycarboxylic acids, ferric hydroxide complexes
GB8902894D0 (en) * 1989-02-09 1989-03-30 Fisons Plc Compositions
JPH0566372A (ja) * 1991-09-10 1993-03-19 Fukui Megane Kogyo Kk 金属製眼鏡フレーム部品の製造方法
JPH0776524A (ja) * 1993-07-13 1995-03-20 Takeda Chem Ind Ltd 動物用抗貧血剤
DK172860B1 (da) 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
JP3504506B2 (ja) 1998-09-17 2004-03-08 株式会社荏原製作所 消音装置
DK173138B1 (da) * 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
EP1762250A1 (en) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
JP5191540B2 (ja) * 2007-08-17 2013-05-08 アクゾ ノーベル ナムローゼ フェンノートシャップ グルタミン酸n,n−二酢酸アミド、グルタミン酸n−酢酸アミドn−アセトニトリル、これらのアルカリ金属塩、それらの調製プロセス及びそれらの使用
TWI469965B (zh) * 2008-12-22 2015-01-21 Ono Pharmaceutical Co 乙炔基吲哚化合物
JP5397991B2 (ja) * 2009-04-01 2014-01-22 学校法人東京農業大学 乳酸菌を用いたビタミンb12の定量方法

Also Published As

Publication number Publication date
HUE044428T2 (hu) 2019-10-28
DK2723774T3 (da) 2019-07-15
CY1121976T1 (el) 2020-10-14
EP2723774A1 (en) 2014-04-30
SI2723774T1 (sl) 2019-08-30
MX2013015075A (es) 2014-04-14
CN105348401A (zh) 2016-02-24
US20140128594A1 (en) 2014-05-08
HK1220218A1 (zh) 2017-04-28
BR112013032901A2 (pt) 2017-01-24
CN103649128A (zh) 2014-03-19
LT2723774T (lt) 2019-08-12
TWI564010B (zh) 2017-01-01
PL2723774T3 (pl) 2019-10-31
EP2537866A1 (en) 2012-12-26
JP6370217B2 (ja) 2018-08-08
JP2018100424A (ja) 2018-06-28
EP2723774B1 (en) 2019-04-03
WO2012175608A1 (en) 2012-12-27
TW201315474A (zh) 2013-04-16
US20160046733A1 (en) 2016-02-18
MX337682B (es) 2016-03-15
CA2837784C (en) 2019-10-15
ES2733767T3 (es) 2019-12-02
US9631032B2 (en) 2017-04-25
JP2014520188A (ja) 2014-08-21
RS59021B1 (sr) 2019-08-30
HRP20191173T1 (hr) 2019-10-04
TR201909574T4 (tr) 2019-08-21
CA2837784A1 (en) 2012-12-27
CN103649128B (zh) 2016-02-10
US9181353B2 (en) 2015-11-10

Similar Documents

Publication Publication Date Title
IL233282A0 (en) Manufacturing process for pyrimidine history
HK1205157A1 (en) Manufacturing process for cyclodextrin derivatives
PT2734499T (pt) Derivados de merocianina
IL247637B (en) History of heteroaryl piperidine
HK1191862A1 (zh) 吡唑衍生物
IL222290A0 (en) Process for preparing aminobenzofuran derivatives
ZA201307428B (en) Thiazole derivatives
IL222191A0 (en) Process for preparing sulfonamido-benzofuran derivatives
IL231950B (en) Aryl-quinoline derivatives
EP2721029A4 (en) IMIDAZOPYRIDIN-2-ONE DERIVATIVES
HK1220218A1 (zh) 用於製造羥乙基澱粉衍生物的方法
IL232838A0 (en) Process for the production of triazinon-benzoxazinones
IL227220A (en) A process for preparing a history of 3-alkylsulfinylbenzoyl
IL227917A0 (en) Methods for the synthesis of starting material z molybdopterin
IL227590B (en) A method for producing derivatives of 1-h-pyrrolidine-4,2-dione
IL232840A0 (en) A process for the production of aryloxyacetamides
IL228486A0 (en) History of 3-ureidoisoquinoline-8-il
IL226097A0 (en) A process for the production of derivatives of 4-carbonyloxyquinoline
EP2734499A4 (en) MEROCYANINE DERIVATIVES
EP2681187A4 (en) METHOD FOR REDUCING ACYLOXY SULFIDE DERIVATIVES